Stephan Eliez Selected Research

DiGeorge Syndrome (Syndrome, DiGeorge)

9/2022	Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
2/2022	Exploring associations between diurnal cortisol, stress, coping and psychopathology in adolescents and young adults with 22q11.2 deletion syndrome.
1/2022	Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial.
1/2021	Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome.
1/2020	Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects.
1/2020	Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome.
1/2018	A Mini Review on the Contribution of the Anterior Cingulate Cortex in the Risk of Psychosis in 22q11.2 Deletion Syndrome.
11/2017	Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
1/2017	Altered structural network architecture is predictive of the presence of psychotic symptoms in patients with 22q11.2 deletion syndrome.
5/2015	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Eliez Research Topics

Disease

15	DiGeorge Syndrome (Syndrome, DiGeorge) 09/2022 - 11/2005
11	Psychotic Disorders (Schizoaffective Disorder) 09/2022 - 01/2008
10	Schizophrenia (Dementia Praecox) 01/2018 - 02/2002
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2022 - 01/2022
2	Cognitive Dysfunction 01/2021 - 04/2015
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2008
2	Autism Spectrum Disorder 01/2017 - 01/2016
1	Congenital Heart Defects (Congenital Heart Defect) 05/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2011

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 10/2018 - 11/2005
5	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2022 - 11/2005
3	Biological ProductsIBA 01/2017 - 11/2005
2	Methylphenidate (Ritalin)FDA LinkGeneric 09/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 04/2015 - 02/2002
2	Dopamine (Intropin)FDA LinkGeneric 12/2011 - 01/2008
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2015